Critically, CAR-NK cells engineered with 2B4-CD3ζ signaling domains demonstrate superior functionality compared to 4-1BB-CD3ζ-based constructs, exhibiting enhanced cytotoxicity, IFN-γ production, and in vivo tumor control (61). The gene discussed is IFNG; the disease is neoplasm.